DK3817775T3 - Forbedringer i immunogene konjugater - Google Patents
Forbedringer i immunogene konjugater Download PDFInfo
- Publication number
- DK3817775T3 DK3817775T3 DK19745001.8T DK19745001T DK3817775T3 DK 3817775 T3 DK3817775 T3 DK 3817775T3 DK 19745001 T DK19745001 T DK 19745001T DK 3817775 T3 DK3817775 T3 DK 3817775T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunogenic conjugates
- immunogenic
- conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693981P | 2018-07-04 | 2018-07-04 | |
| PCT/US2019/040131 WO2020009993A1 (en) | 2018-07-04 | 2019-07-01 | Improvements in immunogenic conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3817775T3 true DK3817775T3 (da) | 2024-09-16 |
Family
ID=67439412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19745001.8T DK3817775T3 (da) | 2018-07-04 | 2019-07-01 | Forbedringer i immunogene konjugater |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP3817775B1 (da) |
| JP (3) | JP7399934B2 (da) |
| KR (1) | KR20210042904A (da) |
| CN (2) | CN112543649B (da) |
| AU (2) | AU2019299836B2 (da) |
| BR (1) | BR112020026899A2 (da) |
| CA (1) | CA3105361A1 (da) |
| DK (1) | DK3817775T3 (da) |
| EA (1) | EA202190168A1 (da) |
| ES (1) | ES2989087T3 (da) |
| IL (1) | IL279855B2 (da) |
| MX (1) | MX2020014118A (da) |
| PH (1) | PH12020552282A1 (da) |
| SG (1) | SG11202012905PA (da) |
| WO (1) | WO2020009993A1 (da) |
| ZA (1) | ZA202100761B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4192499A4 (en) | 2020-08-10 | 2024-09-25 | Inventprise, Inc. | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f |
| KR20230052958A (ko) | 2020-08-19 | 2023-04-20 | 박사이트, 인코포레이티드 | 운반-단백질 폴리삭카라이드 접합 방법 |
| GB202108648D0 (en) * | 2021-06-17 | 2021-08-04 | Inst De Medicina Molecular Joaeo Lobo Antunes | CRM197 protein carrier |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU623598B2 (en) | 1987-06-19 | 1992-05-21 | Terumo Kabushiki Kaisha | Medical instrument and production thereof |
| WO1989006974A2 (en) | 1988-02-01 | 1989-08-10 | Praxis Biologics, Inc. | T-cell epitope as carriers molecule for conjugate vaccines |
| FR2763244B1 (fr) | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| JP2001190665A (ja) | 2000-01-14 | 2001-07-17 | Terumo Corp | シリンジ |
| US20040102388A1 (en) * | 2000-03-22 | 2004-05-27 | High Katherine A. | Modified blood clotting factors and methods of use |
| GB0502095D0 (en) * | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| EP2425853A1 (en) | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
| DK3466982T3 (da) | 2005-04-08 | 2020-08-03 | Wyeth Llc | Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation |
| EP2308504A3 (en) * | 2005-09-01 | 2011-11-30 | Novartis Vaccines and Diagnostics GmbH | Multiple vaccines including serogroup C meningococcus |
| BRPI0620460B8 (pt) | 2005-12-22 | 2021-05-25 | Glaxosmithkline Biologicals Sa | uso de composição imunogênica para bebês, e, processo para produzir uma vacina |
| EP2007427A4 (en) * | 2006-04-11 | 2012-04-04 | Yeda Res & Dev | IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS |
| KR101467002B1 (ko) | 2006-10-10 | 2014-12-01 | 와이어쓰 엘엘씨 | 스트렙토코쿠스 뉴모니애 제3형 다당류의 정제 방법 |
| DK2129693T3 (da) | 2007-03-23 | 2017-02-13 | Wyeth Llc | Afkortet oprensningsfremgangsmåde til fremstilling af streptococcus pneumoniae-kapselpolysaccharider |
| US8609383B2 (en) * | 2008-12-10 | 2013-12-17 | The Scripps Research Institute | Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
| US20120064103A1 (en) | 2009-03-24 | 2012-03-15 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| IT1398927B1 (it) * | 2009-06-25 | 2013-03-28 | Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi | Espressione batterica di un gene artificiale per la produzione di crm197 e derivati. |
| GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP2011212183A (ja) | 2010-03-31 | 2011-10-27 | Terumo Corp | プレフィルドシリンジ |
| MX346245B (es) | 2011-06-01 | 2017-03-13 | Univ Xiamen | Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria. |
| WO2013068949A1 (en) * | 2011-11-07 | 2013-05-16 | Novartis Ag | Carrier molecule comprising a spr0096 and a spr2021 antigen |
| DK2890402T3 (da) | 2012-08-31 | 2019-07-15 | Sutro Biopharma Inc | Modificerede aminosyrer omfattende en azidogruppe |
| CA2885625A1 (en) | 2012-10-02 | 2014-04-10 | Glaxosmithkline Biologicals S.A. | Nonlinear saccharide conjugates |
| KR20140075196A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| WO2014102265A1 (en) * | 2012-12-27 | 2014-07-03 | Glycovaxyn Ag | Methods and compositions relating to crm197 |
| ITMI20130142A1 (it) * | 2013-01-31 | 2014-08-01 | Biosynth Srl | Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati |
| US9840493B2 (en) | 2013-10-11 | 2017-12-12 | Sutro Biopharma, Inc. | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use |
| PL3055321T3 (pl) * | 2013-10-11 | 2019-02-28 | Sutro Biopharma, Inc. | SYNTETAZY tRNA DOŁĄCZAJĄCE AMINOKWAS NIENATURALNY DLA PARA-METYLOAZYDO-L-FENYLOALANINY |
| SI3096783T1 (sl) | 2014-01-21 | 2021-09-30 | Pfizer Inc. | Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati |
| KR20210032013A (ko) | 2014-01-21 | 2021-03-23 | 화이자 인코포레이티드 | 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체 |
| PT3096785T (pt) * | 2014-01-21 | 2020-10-13 | Pfizer | Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas |
| JP2017510290A (ja) | 2014-01-31 | 2017-04-13 | フィナ バイオソリューションズ リミテッド ライアビリティ カンパニー | Ｃｒｍ１９７および関連タンパク質の発現および精製 |
| US10245310B2 (en) * | 2014-08-05 | 2019-04-02 | Glaxosmithkline Biologicals Sa | Carrier molecule for antigens |
| EP3436061A4 (en) * | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide-conjugate compositions and methods of use thereof |
| PH12019500672B1 (en) * | 2016-09-30 | 2024-02-23 | Biological E Ltd | Multivalent pneumococcal vaccine compositions comprising polysachharide-protein conjugates |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
-
2019
- 2019-07-01 DK DK19745001.8T patent/DK3817775T3/da active
- 2019-07-01 IL IL279855A patent/IL279855B2/en unknown
- 2019-07-01 ES ES19745001T patent/ES2989087T3/es active Active
- 2019-07-01 WO PCT/US2019/040131 patent/WO2020009993A1/en not_active Ceased
- 2019-07-01 CN CN201980044169.8A patent/CN112543649B/zh active Active
- 2019-07-01 BR BR112020026899-2A patent/BR112020026899A2/pt unknown
- 2019-07-01 CA CA3105361A patent/CA3105361A1/en active Pending
- 2019-07-01 EP EP19745001.8A patent/EP3817775B1/en active Active
- 2019-07-01 JP JP2021500060A patent/JP7399934B2/ja active Active
- 2019-07-01 SG SG11202012905PA patent/SG11202012905PA/en unknown
- 2019-07-01 MX MX2020014118A patent/MX2020014118A/es unknown
- 2019-07-01 KR KR1020217003324A patent/KR20210042904A/ko active Pending
- 2019-07-01 CN CN202610316960.1A patent/CN121971595A/zh active Pending
- 2019-07-01 EA EA202190168A patent/EA202190168A1/ru unknown
- 2019-07-01 EP EP24197275.1A patent/EP4483896A3/en active Pending
- 2019-07-01 AU AU2019299836A patent/AU2019299836B2/en active Active
-
2020
- 2020-12-29 PH PH12020552282A patent/PH12020552282A1/en unknown
-
2021
- 2021-02-03 ZA ZA2021/00761A patent/ZA202100761B/en unknown
-
2023
- 2023-12-06 JP JP2023206041A patent/JP7796716B2/ja active Active
-
2025
- 2025-10-21 AU AU2025256067A patent/AU2025256067A1/en active Pending
- 2025-12-23 JP JP2025278934A patent/JP2026071217A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021530468A (ja) | 2021-11-11 |
| EP4483896A2 (en) | 2025-01-01 |
| EA202190168A1 (ru) | 2021-06-07 |
| KR20210042904A (ko) | 2021-04-20 |
| EP3817775B1 (en) | 2024-09-04 |
| AU2025256067A1 (en) | 2025-11-13 |
| AU2019299836A1 (en) | 2021-02-25 |
| CA3105361A1 (en) | 2020-01-09 |
| JP2024037805A (ja) | 2024-03-19 |
| EP4483896A3 (en) | 2025-04-02 |
| IL279855B2 (en) | 2026-01-01 |
| CN121971595A (zh) | 2026-05-05 |
| AU2019299836B2 (en) | 2025-08-21 |
| PH12020552282A1 (en) | 2021-06-28 |
| SG11202012905PA (en) | 2021-01-28 |
| CN112543649A (zh) | 2021-03-23 |
| JP7796716B2 (ja) | 2026-01-09 |
| JP7399934B2 (ja) | 2023-12-18 |
| BR112020026899A2 (pt) | 2021-03-30 |
| MX2020014118A (es) | 2021-06-18 |
| IL279855A (en) | 2021-03-01 |
| ZA202100761B (en) | 2025-05-28 |
| JP2026071217A (ja) | 2026-04-28 |
| ES2989087T3 (es) | 2024-11-25 |
| EP3817775A1 (en) | 2021-05-12 |
| WO2020009993A1 (en) | 2020-01-09 |
| CN112543649B (zh) | 2026-03-31 |
| IL279855B1 (en) | 2025-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3807644A4 (en) | ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | |
| DK3592393T3 (da) | Frigørbare konjugater | |
| EP3554266A4 (en) | ANTIBODY-DRUG CONJUGATES MULTI-DRUG | |
| DK3579883T3 (da) | Pyrrolobenzodiazepin-antistofkonjugater | |
| MA51778A (fr) | Conjugués anticorps-médicament anti-ccr7 | |
| EP3582790A4 (en) | VERY POWERFUL IMMUNOGENIC COMPOSITIONS | |
| LT3525830T (lt) | Pirolbenzodiazepino konjugatai | |
| DK3380124T3 (da) | Konjugater omfattende selv-immolative grupper og fremgangsmåder relateret dertil | |
| DK3096785T3 (da) | Immunogene sammensætninger omfattende konjugerede kapsel-saccharid-antigener og anvendelser deraf | |
| EP3313857A4 (en) | POLYMER-CYCLODEXTRIN LIPID CONJUGATES | |
| DK3137114T3 (da) | Anti-PTK7-antistof-lægemiddelkonjugater | |
| DK3268047T3 (da) | Amatoxin/antistof-konjugater | |
| EP3655029C0 (en) | IMMUNOGENE COMPOSITION | |
| LT3544636T (lt) | Pirolobenzodiazepino-antikūno konjugatai | |
| DK3297649T3 (da) | Peptid-oligonukleotid-konjugater | |
| PL3151865T3 (pl) | Koniugacja w określonym miejscu leków-łączników z przeciwciałami oraz powstałe w jej wyniku koniugaty przeciwciało-lek (ADCs) | |
| CY1125598T1 (el) | Συζευγματα πυρρολοβενζοδιαζεπινης | |
| IL281051A (en) | Immunoconjugates targeting egfr | |
| DK3166638T3 (da) | Nyttelagt-polymer-proteinkonjugater | |
| DK3668874T3 (da) | Pyrrolobenzodiazepin-konjugater | |
| EP3355931C0 (en) | PROTEIN CONJUGATES | |
| DK3478323T3 (da) | Spaltbare polymer-lægemiddelkonjugater | |
| DK3684416T3 (da) | Psma-målrettede amanitinkonjugater | |
| EP3430060A4 (en) | CONJUGATES FOR IMPROVING TOTAL CELLULAR ACCUMULATION | |
| DK3544634T3 (da) | MET-antistof-lægemiddelkonjugater |